Skip to main content
. 2021 Feb 5;10(2):1. doi: 10.1167/tvst.10.2.1

Table 1.

Group Demographics and Clinical Characteristics

Characteristics Neuro-Ophthalmologic Disorders (N = 37) Glaucoma (N = 15) Controls (N = 21)
Age (y) 36.9 (12.5) 43.9 (12.5) 38 (15.05)
Age Range (y) 18–73 24–61 20–67
Male (sex) 15 (40.5) 10 (66.6) 15 (71.4)
BCVA 0.78 (0.27) 0.72 (0.27) 0.89 (0.1)
BCVA Range 0.25–1 0.25–1 0.7–1
Subtypes Temporal disc pallor (n = 7) POAG (n = 9)
Toxic optic neuropathy (n = 5) Steroid-induced glaucoma (n = 2)
Optic neuritis (n = 4) JOAG (n = 3)
Pituitary adenoma (n = 6) PACG (n = 1)
TONP (n = 3)
Secondary optic atrophy (n = 2)
Papilloedema (n = 4)
IIH (n = 2)
NAION (n = 2)
Brain infarction with parietal lobe involvement (n = 1)
Brain infarction with occipital lobe involvement (n = 1)

Values are represented as mean (SD) or number (%). The P value for the differences in age group means for the three groups was 0.22.

IIH, idiopathic intracranial hypertension; JOAG, juvenile open-angle glaucoma; NAION, nonarteritic anterior ischemic optic neuropathy; PACG, primary angle closure glaucoma; TONP, temporal optic nerve pallor.